Lmr Partners LLP Aerovate Therapeutics, Inc. Put Options Transaction History

Lmr Partners LLP

  • $18.1 Billion
  • Q3 2025

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.41 - $30.75 $19,881 - $433,575
14,100 New
14,100 $23,000

Others Institutions Holding AVTE

# of Institutions
3
Shares Held
1.63M
Call Options Held
0
Put Options Held
0
View Full List

About Aerovate Therapeutics, Inc.

AVTE Quotes by TradingView
  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $65.5M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email